Major Novartis shareholder calls for board shake-up after drug trial setbacks: Reuters exclusive

Artisan Partners, a significant shareholder in Novartis, has called for a shake-up of the Swiss drugmaker's board to enhance corporate governance. This demand follows recent drug trial setbacks that resulted in a record fall in the company's shares.